MyAverix Finance
TWO · Healthcare
TCI GENE Inc. (6879)
Biotechnology
TCI GENE Inc. (6879) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $941.92M, P/E ratio is 23.42, net margin is 11.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6879
TCI GENE Inc. (6879) — FAQ
What is TCI GENE Inc.'s market cap?
TCI GENE Inc. (6879) has a reported market cap of $941.92M (data as of 2026-03-29).
What is 6879's P/E ratio?
The price-to-earnings (P/E) ratio for TCI GENE Inc. (6879) is 23.42 (data as of 2026-03-29).
Does TCI GENE Inc. pay a dividend?
Dividend yield is not available in the current snapshot for TCI GENE Inc. (6879). Check the MyAverix Finance app for the latest dividend data.
What sector is TCI GENE Inc. in?
TCI GENE Inc. (6879) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6879 listed on?
6879 is listed on TWO.
What is TCI GENE Inc.'s net margin?
TCI GENE Inc. (6879) reports a net margin of 11.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.